Cigna Group (NYSE:CI) Receives $339.45 Average Price Target from Analysts

Cigna Group (NYSE:CI) has earned a consensus recommendation of “Moderate Buy” from the twenty-three ratings firms that are presently covering the firm, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $337.0952.

Several equities analysts have weighed in on CI shares. UBS Group increased their target price on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 29th. Sanford C. Bernstein increased their price target on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Wolfe Research restated an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Finally, Mizuho increased their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole Jones sold 19,436 shares of the stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 23,629 shares of company stock valued at $6,561,809. Company insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Cigna Group

Institutional investors have recently added to or reduced their stakes in the stock. Assetmark Inc. increased its position in Cigna Group by 10.0% during the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after buying an additional 5,963 shares during the period. Mystic Asset Management Inc. acquired a new position in shares of Cigna Group in the second quarter valued at about $2,808,000. KBC Group NV grew its stake in shares of Cigna Group by 6.4% in the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after acquiring an additional 22,978 shares in the last quarter. Sanctuary Advisors LLC bought a new position in Cigna Group during the second quarter worth about $11,043,000. Finally, Trust Co. of Vermont acquired a new stake in Cigna Group in the 2nd quarter worth about $4,231,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Trading Up 0.9%

Shares of CI opened at $278.29 on Friday. The stock’s fifty day simple moving average is $283.60 and its 200-day simple moving average is $280.78. The firm has a market capitalization of $73.54 billion, a PE ratio of 11.51, a price-to-earnings-growth ratio of 0.95 and a beta of 0.31. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the previous year, the company earned $7.20 EPS. Cigna Group’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is currently 25.82%.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.